• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 45007
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism/Embolus (4438)
Event Date 09/04/2023
Event Type  Injury  
Event Description
It was reported that slow flow occurred.The patient presented with recurrent chronic ischemia (rutherford 6) affecting the left lower extremity with gangrene of the left heel.A left lower extremity arteriography was performed via an antegrade left common femoral artery approach, with placement of a 7 french sheath.Left lower extremity arteriography demonstrated moderate to severe calcified atherosclerotic plaque within the mid and distal superficial femoral artery (sfa) with multifocal segmental stenoses, the greatest of which was greater than 90% reduction in luminal diameter.There were two vessel runoffs via a diminutive peroneal artery (dpa) and dominant runoff to the left foot via the anterior tibial artery (at) and dorsalis pedis (dp) arteries.There was a focal significant stenosis within the distal anterior tibial artery.A jetstream sc 1.6 mm device was utilized with blades down.Subsequently, embolic protection was deployed using an 8 mm non-boston scientific device into the popliteal artery.A jetstream 2.1 mm device was utilized with blades down.A 5 mm x 100 mm ranger dcb was then utilized to treat the left sfa.Follow up arteriography of the left sfa was performed during these procedures which demonstrated an excellent angiographic result; however, the below knee segment was only evaluated after removal of the embolic protection device and after ranger dcb.This demonstrated very slow flow in both the peroneal and anterior tibial arteries with occlusion of the distal ata and dpa.The physician tried to cross the ata from an antegrade approach which was unsuccessful.He performed successful retrograde dpa access ultimately reversing the access to perform vasodilator infusion, aspiration with a standard 4 f endhole catheter (not a dedicated aspiration catheter) and 2 mm in diameter angioplasty of the ata and dpa.Final arteriography demonstrated re-established patency of the ata and dpa with relatively slow flow and no washout into the pedal arteries.Post-procedure the patient foot was cool.The patient and family did not want additional intervention to be performed.Over the next 7 days, the leg became progressively ischemic which would have indicated an amputation, which the patient and family declined.By 14 days, the toes were dusky and blistering ensued.By 21 days, worsening gangrene occurred, now progressing through the calf.The patient expired 33 days post-procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM XC
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork T12 Y K88
EI   T12 YK88
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18097499
MDR Text Key327696627
Report Number2124215-2023-60685
Device Sequence Number1
Product Code MCW
UDI-Device Identifier08714729889892
UDI-Public08714729889892
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K133023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number45007
Device Catalogue Number45007
Device Lot Number0029584957
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-